BOC Sciences Introduces Computer-Aided Drug Discovery for the Science Community

April 17 16:34 2019
BOC Sciences Introduces Computer-Aided Drug Discovery for the Science Community

Computer-Aided Drug Discovery
BOC Sciences, a New York- based chemical company announces to introduce a comprehensive computer-aided drug discovery service (CADD) including compound docking, virtual screening, activity prediction, QSAR prediction and physicochemical prediction for the science community.

On April 16, 2019, BOC Sciences, a New York- based chemical company announces to introduce a comprehensive computer-aided drug discovery service (CADD) including compound docking, virtual screening, activity prediction, QSAR prediction and physicochemical prediction for the science community. BOC Sciences has long been actively involved in advancing drug development for the wellbeing of mankind with concerted efforts from the industry. This move is made by the management to better facilitate researchers and scientists in the pharmaceutical industry.

The traditional process for discovering new drugs is usually laborious, expensive and inelegant, which largely relies on the experience and intuition of the chemists to ultimately select a candidate for further development. A large number of experiments are needed before the lead with the most desired biological properties is found. In contrast to these traditional drug design methods, CADD has been warmly received and applied as a highly effective tool for systematic assessment of potential lead candidates before they are synthesized and tested, thus saving both time and cost in drug discovery.

“With computer-aided drug design and high throughput screening methods, we can search new hits in lead discovery and screen many irrelevant compounds in a more efficient manner, and at the same time study the structure-activity relationship of drug molecules,” says Mr. Barron Jones, the Marketing Chief of BOC Sciences. “We use computational tools and resources to store, manage, analyze and model compounds. And thanks to the digital repositories for the study of designing compounds with physicochemical characteristics, it’s much easier to predict whether a given molecule will be combined with the target, and if so how strongly the binding is.” 

From start to end, the CADD process covers steps like compound docking, virtual screening, activity prediction, QSAR prediction and physicochemical prediction. Among them, docking study is of great importance in the structure-based drug design as it plays an important role in the QSAR methods and homology modeling.

With industry-standard software and hardware, proprietary design concepts and tools, the experienced scientists at BOC Sciences aims to help with addressing those pressing drug discovery issues across the industry and by the end of 2018 it had a good track record of success. For more information about BOC Sciences’ computer-aided drug discovery service, please visit:  https://www.bocsci.com/solutions/computational-chemistry.htm.

About BOC Sciences

Dedicated to become a trust-worthy brand, BOC Sciences strives to offer strategies and solutions to assist resolve the industry’s most pressing drug development issues. To this end, it provides comprehensive medicinal chemistry services, custom synthesis, analysis/purification, formulation services for pharmaceutical companies engaged in drug discovery and research.

Media Contact
Company Name: BOC Sciences
Contact Person: Alex Brown
Email: Send Email
Phone: 16316197922
Address:45-16 Ramsey Road
City: Shirley
State: NY
Country: United States
Website: https://www.bocsci.com/solutions/

  Categories: